Physician profile
Eric Spencer
NPI 1689105611
$2,632.30
in general payments reported to CMS, 2019-2025
20 companies · $209 in 2025
The $209 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.98 · 2020: $30.64 · 2021: $207 · 2022: $784 · 2023: $748 · 2024: $590 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,546.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $871.15 | 2019-2024 | Ubrelvy, Qulipta, Botox |
| Pfizer INC. | $517.95 | 2023-2024 | |
| Amgen INC. | $261.29 | 2021-2025 | Repatha |
| Lilly USA, LLC | $220.35 | 2021-2025 | Emgality, Reyvow, Mounjaro |
| Biohaven Pharmaceutical Holding Company Ltd. | $172.06 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $118.60 | 2023-2024 | Ajovy |
| Lundbeck LLC | $106.80 | 2021-2022 | |
| Abbott Laboratories | $44.35 | 2024-2025 | Freestyle Libre 3, Proclaim |
| Csl Behring | $41.92 | 2022 | |
| Novo Nordisk INC | $37.61 | 2024 | Wegovy |
| Upsher-Smith Laboratories LLC | $36.56 | 2020-2021 | |
| Supernus Pharmaceuticals, INC. | $36.19 | 2025 | Qelbree |
| Alnylam Pharmaceuticals INC. | $29.05 | 2024 | Onpattro |
| Allergan, INC. | $25.39 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $24.32 | 2025 | Airsupra |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $23.62 | 2025 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $20.75 | 2025 | Trintellix |
| Dexcom, INC. | $17.37 | 2025 | Dexcom G6 Transmitter |
| Nevro Corp. | $15.94 | 2024 | Senza |
| Amneal Pharmaceuticals LLC | $11.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Spencer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.